Corindus Brings In Boston Scientific Exec To Head Sales
This article was originally published in Clinica
Corindus Vascular Robotics, Inc. has named Gary Lickovitch Vice President of Sales and Service. The appointment was announced Oct. 6, a day after the company said it has secured US FDA clearance for its CorPath robotic system for percutaneous coronary interventions. Lickovitch joins from Boston Scientific, where he was Area Vice-President for the Interventional Cardiology Division and was responsible for sales execution and strategy. He has also held other sales roles at Abbott Vascular and CR Bard. Corindus claims CorPath is the first device of its kind to get US regulatory approval. The robotically-assisted system allows interventional cardiologist to advance stents and guidewires with millimetre-by-millimeter precision; as the cardiologist is performing the procedure behind a console, without the need to wear lead protective equipment, they have more comfort and freedom.